Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin ...

Foghorn Therapeutics Inc. (FHTX ... conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here ...

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

Foghorn Therapeutics Inc. announced continued enrollment in its Phase 1 trial for FHD-909, a first-in-class oral selective SMARCA2 inhibitor targeting SMARCA4 mutated cancers, particularly non ...

March 06, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting ...

Though the neighborhood is normally relatively peaceful, Mainville said the malfunctioning foghorn at the end of the jetty is testing his nerves. “Over and over and over,” he said.

NARRANGANSETT, R.I. (WJAR/CNN Newsource/WKRC) - Imagine going for a walk in the park, getting some work done, or even going to sleep, all while a loud foghorn blares through your town every 30 ...